22nd Century Group, Inc. (NYSE: XXII) Starts Presentation at LD Micro Main Event
22nd Century (NYSE: XXII) is a plant biotechnology company focused on genetic engineering and plant breeding which allows the increase or decrease of the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants. The company’s primary mission in tobacco is to reduce the harm caused by smoking. The company’s primary mission in cannabis is to develop proprietary hemp/cannabis strains for important new medicines and agricultural crops. For more information, visit the company’s website at www.xxiicentury.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2)…







